The results suggest cell salvage is efficacious in reducing the need for allogeneic red cell transfusion in adult elective cardiac and orthopaedic surgery. The use of cell salvage did not appear to impact adversely on clinical outcomes. However, the methodological quality of trials was poor. As the trials were unblinded and lacked adequate concealment of treatment allocation, transfusion practices may have been influenced by knowledge of the patients' treatment status potentially biasing the results in favour of cell salvage.
[Blood-saving effectiveness of preoperative reservation of autoblood for surgical treatment of ischemic heart disease].
A randomized prospective investigation included 143 patients (coronary shunting for IHD under conditions of extracorporeal circulation--EC). In 55 patients exfusion of autoblood followed by its transfusion after finishing EC was made before operation in 88 patients. A cell saver was used in all the patients from the moment of cutting the skin for the collection of blood and for the collection of perfusate left in the EC apparatus after finishing EC and for autotransfusion of the drainage fluid released after operation. The preoperative reservation of autoblood in patients with IHD for operations of coronary bypass under conditions of EC and using the cell saver gives higher values of hemoglobin and erythrocytes by the moment of discharge of the patients from the hospital, but non the less does not reduce the frequency of using homologous blood.